Shiraoka, Japan

Keiichiro Otsuka

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiichiro Otsuka: Innovator in Nucleic Acid Delivery Systems

Introduction

Keiichiro Otsuka is a prominent inventor based in Shiraoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of compositions for delivering nucleic acids. His work aims to enhance the efficacy and safety of nucleic acid drugs.

Latest Patents

Otsuka holds a patent for a composition designed for delivering nucleic acids. This innovative composition ensures the stability of nucleic acid drugs, achieves a high intracellular introduction rate, and efficiently expresses the function of the nucleic acid while maintaining low cytotoxicity. The patent discloses a composition that includes a block copolymer with a polyethylene glycol segment linked to a hydrophobic polyester segment, along with a peptide containing 4 to 30 residues, which includes at least one amino acid selected from arginine and lysine.

Career Highlights

Keiichiro Otsuka is affiliated with the Tokyo University of Pharmacy & Life Sciences, where he continues to advance research in the field of drug delivery systems. His work is pivotal in addressing the challenges associated with nucleic acid therapeutics.

Collaborations

Otsuka collaborates with notable colleagues, including Takanori Kanazawa and Yuuki Takashima. Their combined expertise contributes to the advancement of innovative solutions in biotechnology.

Conclusion

Keiichiro Otsuka's contributions to nucleic acid delivery systems represent a significant advancement in biotechnology. His innovative approaches have the potential to improve the effectiveness of nucleic acid-based therapies, paving the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…